Also making headlines, researchers in Britain say they have found a drug used to treat leukemia can halt and even reverse the effects of multiple sclerosis, which causes the immune system to attack nerve fibres.
The report, published in the New England Journal of Medicine says a drug called Alemtuzumab may stop the advance of m-s in its early stages. In trials, the drug cut the number of attacks and helped them recover lost functions.
The MS Society said the results of this trial will bring hope to thousands living with the condition.
